158 related articles for article (PubMed ID: 9050258)
41. Optimal visual perception and detection of oral cavity neoplasia.
Utzinger U; Bueeler M; Oh S; Heintzelman DL; Svistun ES; Abd-El-Barr M; Gillenwater A; Richards-Kortum R
IEEE Trans Biomed Eng; 2003 Mar; 50(3):396-9. PubMed ID: 12669997
[TBL] [Abstract][Full Text] [Related]
42. [Precancerous lesions of the buccal mucosa].
Ben Slama L
Rev Stomatol Chir Maxillofac; 2001 Apr; 102(2):77-108. PubMed ID: 11446145
[TBL] [Abstract][Full Text] [Related]
43. Screening for oral potentially malignant epithelial lesions and squamous cell carcinoma: a discussion of benefit and risk.
Epstein JB
J Can Dent Assoc; 2014; 80():e47. PubMed ID: 25055237
[No Abstract] [Full Text] [Related]
44. An in vitro diagnosis of oral premalignant lesion using time-resolved fluorescence spectroscopy under UV excitation-a pilot study.
Kanniyappan U; Prakasarao A; Dornadula K; Singaravelu G
Photodiagnosis Photodyn Ther; 2016 Jun; 14():18-24. PubMed ID: 26853635
[TBL] [Abstract][Full Text] [Related]
45. p53 immunoexpression in non-malignant oral mucosa adjacent to oral squamous cell carcinoma: potential consequences for clinical management.
Cruz IB; Meijer CJ; Snijders PJ; Snow GB; Walboomers JM; van Der Waal I
J Pathol; 2000 Jun; 191(2):132-7. PubMed ID: 10861571
[TBL] [Abstract][Full Text] [Related]
46. Expression of BUBR1 in human oral potentially malignant disorders and squamous cell carcinoma.
Hsieh PC; Chen YK; Tsai KB; Shieh TY; Chang YY; Chang JG; Wu HL; Lin SF
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Feb; 109(2):257-67. PubMed ID: 19926498
[TBL] [Abstract][Full Text] [Related]
47. Narrow band (light) imaging of oral mucosa in routine dental patients. Part I: Assessment of value in detection of mucosal changes.
Truelove EL; Dean D; Maltby S; Griffith M; Huggins K; Griffith M; Taylor S
Gen Dent; 2011; 59(4):281-9; quiz 290-1, 319-20. PubMed ID: 21903568
[TBL] [Abstract][Full Text] [Related]
48. [Detection of potentially malignant and malignant lesions of oral cavity using autofluorescence visualization device].
Matsumoto K
Kokubyo Gakkai Zasshi; 2011 Jun; 78(2):73-80. PubMed ID: 21827020
[TBL] [Abstract][Full Text] [Related]
49. [The clinical evaluation of Oratest in detecting oral mucosal lesions].
Cheng B; Yang L
Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Apr; 21(2):124-6. PubMed ID: 12838698
[TBL] [Abstract][Full Text] [Related]
50. Discrimination of normal, inflammatory, premalignant, and malignant oral tissue: a Raman spectroscopy study.
Malini R; Venkatakrishna K; Kurien J; Pai KM; Rao L; Kartha VB; Krishna CM
Biopolymers; 2006 Feb; 81(3):179-93. PubMed ID: 16231284
[TBL] [Abstract][Full Text] [Related]
51. Detecting oral cancer: a new technique and case reports.
Kois JC; Truelove E
Dent Today; 2006 Oct; 25(10):94, 96-7. PubMed ID: 17058395
[TBL] [Abstract][Full Text] [Related]
52. Diagnosis of oral premalignant and malignant lesions using cytomorphometry.
Ramaesh T; Mendis BR; Ratnatunga N; Thattil RO
Odontostomatol Trop; 1999 Mar; 22(85):23-8. PubMed ID: 11372099
[TBL] [Abstract][Full Text] [Related]
53. Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors.
Lee JJ; Hung HC; Cheng SJ; Chen YJ; Chiang CP; Liu BY; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Apr; 101(4):472-80. PubMed ID: 16545712
[TBL] [Abstract][Full Text] [Related]
54. Autofluorescence and early detection of mucosal lesions in patients at risk for oral cancer.
Moro A; Di Nardo F; Boniello R; Marianetti TM; Cervelli D; Gasparini G; Pelo S
J Craniofac Surg; 2010 Nov; 21(6):1899-903. PubMed ID: 21119451
[TBL] [Abstract][Full Text] [Related]
55. Loss of ELF3 immunoexpression is useful for detecting oral squamous cell carcinoma but not for distinguishing between grades of epithelial dysplasia.
AbdulMajeed AA; Dalley AJ; Farah CS
Ann Diagn Pathol; 2013 Aug; 17(4):331-40. PubMed ID: 23643910
[TBL] [Abstract][Full Text] [Related]
56. [Optical coherence tomography in the evaluation of the oral cavity mucosa. Part II. Benign and malignant diseases].
Fomina IuV; Gladkova ND; Leont'ev VK; Urutina MN; Gazhva SI; Snopova LB; Gelikonov VM; Kamenskiĭ VA
Stomatologiia (Mosk); 2004; 83(4):25-32. PubMed ID: 15340301
[TBL] [Abstract][Full Text] [Related]
57. In vivo Raman spectroscopy of oral buccal mucosa: a study on malignancy associated changes (MAC)/cancer field effects (CFE).
Singh SP; Sahu A; Deshmukh A; Chaturvedi P; Krishna CM
Analyst; 2013 Jul; 138(14):4175-82. PubMed ID: 23392131
[TBL] [Abstract][Full Text] [Related]
58. [Leukoplakia and erythroplakia--two orale precursor lesions].
Grajewski S; Groneberg D
Laryngorhinootologie; 2009 Oct; 88(10):666-72; quiz 673-5. PubMed ID: 19813163
[TBL] [Abstract][Full Text] [Related]
59. In vivo autofluorescence characteristics of pre- and post-treated oral submucous fibrosis: a pilot study.
Vedeswari CP; Jayachandran S; Ganesan S
Indian J Dent Res; 2009; 20(3):261-7. PubMed ID: 19884705
[TBL] [Abstract][Full Text] [Related]
60. Noninvasive fluorescence excitation spectroscopy for the diagnosis of oral neoplasia in vivo.
Ebenezar J; Ganesan S; Aruna P; Muralinaidu R; Renganathan K; Saraswathy TR
J Biomed Opt; 2012 Sep; 17(9):97007-1. PubMed ID: 23085924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
